Use of Pembrolizumab Expanded to 13th Type of Cancer in Five Years
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Category: Policy
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
In the effort to include more diverse patient populations in clinical trials, good intentions can easily go awry. Panelists...
Policy plays a critical role in the fight against cancer, influencing the funding of cancer research and driving the...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
In the past year, the number of American teenagers using tobacco products has increased by nearly 40 percent, reversing...
The tobacco product landscape is evolving and the AACR Tobacco Products and Cancer Subcommittee has been cognizant of the...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...